Overview of Short-Term and Long-Term Safety of Brexpiprazole in Patients with Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

By  

Current Psychiatry Reviews, Vol. 12, Iss. 3, 2016-12 ,pp. : 278-290

Bentham Science Publishers

Access to resources Recommend Favorite

Cost effectiveness analysis of escitalopram compared to venlafaxine and fluvoxamine in treatment of major depressive disorder

By Xie Feng   Despiegel Nicolas   Danchenko Natalya   Hansen Karina  

International Journal of Psychiatry in Clinical Practice, Vol. 13, Iss. 1, 2009-03 ,pp. : 59-69

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A Double-Blind Comparison of Escitalopram and Paroxetine in the Long-Term Treatment of Generalized Anxiety Disorder

By Bielski Robert   Bose Anjana   Chang Chung-Chi  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 17, Iss. 2, 2005-04 ,pp. : 65-69

Informa Healthcare

Access to resources Recommend Favorite

Comparison of major depressive disorder and subthreshold depression among older adults in community long-term care

By Lee Mi Jin  

Aging and Mental Health, Vol. 17, Iss. 4, 2013-05 ,pp. : 461-469

Routledge Ltd

Access to resources Recommend Favorite

Escitalopram in major depressive disorder: clinical benefits and cost effectiveness versus citalopram

By Lançon Christophe   Verpillat Patrice   Annemans Lieven   Despiegel Nicolas   François Clément  

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 1, 2007-01 ,pp. : 44-52

Ashgate Publishing Ltd

Access to resources Recommend Favorite